Literature DB >> 29369960

Risk of Acute Ischemic Stroke in Patients With Monocular Vision Loss of Vascular Etiology.

Lucy Y Zhang1, Jason Zhang, Richard K Kim, Jared L Matthews, Danielle S Rudich, David M Greer, Robert L Lesser, Hardik Amin.   

Abstract

BACKGROUND: To evaluate the risk of concurrent acute ischemic stroke and monocular vision loss (MVL) of vascular etiology.
DESIGN: Retrospective, cross-sectional study.
SUBJECTS: Patients aged 18 or older diagnosed with MVL of suspected or confirmed vascular etiology who had no other neurologic deficits and who received brain MRI within 7 days of onset of visual symptoms were included.
METHODS: A medical record review was performed from 2013 to 2016 at Yale New Haven Hospital. Patients were included if vision loss was unilateral and due to transient monocular vision loss (TMVL), central retinal artery occlusion (CRAO), or branch retinal artery occlusion (BRAO). Any patients with neurologic deficits other than vision loss were excluded. Other exclusion criteria were positive visual phenomena, nonvascular intraocular pathology, and intracranial pathology other than ischemic stroke. MAIN OUTCOME MEASURES: The presence or absence of acute stroke on diffusion-weighted imaging (DWI) on brain MRI.
RESULTS: A total of 641 records were reviewed, with 293 patients found to have MVL. After excluding those with focal neurologic deficits, there were 41 patients who met the inclusion criteria and received a brain MRI. Eight of the 41 subjects (19.5%) were found to have findings on brain MRI positive for acute cortical strokes. The proportion of lesion positive MRI was 1/23 (4.3%) in TMVL subjects, 4/12 (33.3%) in CRAO subjects, and 2/5 (40%) in BRAO subjects. Brain computed tomography (CT) scans were not able to identify the majority of acute stroke lesions in this study.
CONCLUSIONS: Patients with MVL of vascular etiology such as TMVL, CRAO, or BRAO may have up to 19.5% risk of concurrent ischemic stroke, even when there are no other neurologic deficits. These strokes were detected acutely with brain MRI using DWI but were missed on CT.

Entities:  

Mesh:

Year:  2018        PMID: 29369960     DOI: 10.1097/WNO.0000000000000613

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  8 in total

1.  The brain and eye: Treating cerebral and retinal ischemia through mitochondrial transfer.

Authors:  Matt Heyck; Brooke Bonsack; Henry Zhang; Nadia Sadanandan; Blaise Cozene; Chase Kingsbury; Jea-Young Lee; Cesar V Borlongan
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-11

Review 2.  [Nonaretritic central retinal artery occlusion as marker for the generalized vascular risk].

Authors:  Nicolas Feltgen; Jan Liman; Maximilian Schultheiss; Martin S Spitzer; Amelie Pielen; Sven Poli
Journal:  Ophthalmologe       Date:  2021-08-04       Impact factor: 1.059

Review 3.  Retinal vascular occlusions.

Authors:  Ingrid U Scott; Peter A Campochiaro; Nancy J Newman; Valérie Biousse
Journal:  Lancet       Date:  2020-12-12       Impact factor: 202.731

4.  Eye Opener in Stroke.

Authors:  Hung Nguyen; Jea Young Lee; Paul R Sanberg; Eleonora Napoli; Cesar V Borlongan
Journal:  Stroke       Date:  2019-06-27       Impact factor: 10.170

5.  Central Retinal Artery Occlusion Associated with Carotid Artery Occlusion.

Authors:  Wells Weymouth; Craig Pedersen
Journal:  Clin Pract Cases Emerg Med       Date:  2019-05-21

6.  The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion.

Authors:  Marlena Schnieder; Charlotte V Fischer-Wedi; Sebastian Bemme; Mai-Linh Kortleben; Nicolas Feltgen; Jan Liman
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

7.  Associations among Stroke, Myocardial Infarction, and Amaurosis Fugax in a Tertiary Referral Hospital in Taiwan.

Authors:  Ming-Hui Sun; Nomin-Erdene Ognoo
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

8.  Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision!

Authors:  Oana M Dumitrascu; Nancy J Newman; Valérie Biousse
Journal:  J Neuroophthalmol       Date:  2020-09       Impact factor: 4.415

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.